MEIOC: A Protein Involved in Cancer Development and Placenta Function

Target Name: MEIOC

NCBI ID: G284071

MEIOC

MEIOC: A Protein Involved in Cancer Development and Placenta Function

MEIOC (MEIOC_HUMAN) is a protein that is expressed in the human placenta and has been shown to play a role in the development and maintenance of cancer. It is a member of the integrin family, which is a group of proteins that are involved in cell-cell and cell-matrix interactions.

MEIOC is localized to the outer layer of the placenta, where it is involved in the formation of blood vessels and plays a role in the delivery of nutrients and oxygen to the developing fetus. It is also involved in the regulation of cell growth and in the development of cancer.

One of the key functions of MEIOC is its role in the development of cancer.MEIOC has been shown to promote the growth and survival of cancer cells, and it is often used as a drug target or biomarker for cancer.

Research has also shown that MEIOC is involved in the regulation of cell death, and that it can be used to inhibit the growth and survival of cancer cells. This makes it an attractive target for cancer treatment, as it can be used to prevent the development and progression of cancer.

Another function of MEIOC is its role in the regulation of cell adhesion.MEIOC is involved in the formation of tight junctions, which are a type of cell adhesion that helps to maintain the integrity of tissues.

Research has also shown that MEIOC is involved in the regulation of cell migration.MEIOC is involved in the formation of the actin cytoskeleton, which is a protein that helps to maintain the shape and movement of cells. This makes it an attractive target for the development of drugs that can inhibit cell migration and promote the growth of cancer cells.

In conclusion, MEIOC is a protein that is expressed in the human placenta and has been shown to play a role in the development and maintenance of cancer. It is a member of the integrin family and is involved in the regulation of cell growth, cell death, and cell adhesion.MEIOC is also involved in the regulation of cell migration and has been shown to promote the growth and survival of cancer cells. This makes it an attractive target for the development of drugs that can inhibit cell migration and promote the growth of cancer cells.

Protein Name: Meiosis Specific With Coiled-coil Domain

Functions: Is required for meiosis completion in both male and female germ cells. Confers stability to numerous meiotic mRNAs in gonads allowing proper initiation and progression into meiosis prophase I. The function may involve YTHDC2 and is independent of induction by retinoic acid (RA). Maintains an extended meiotic prophase I by properly promoting the transition from a mitotic to a meiotic cell cycle program by binding transcripts through its interaction with YTHDC2 that regulate the mitotic cell cycle

The "MEIOC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MEIOC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets